Towards endometriosis diagnosis by gadofosveset-trisodium enhanced magnetic resonance imaging

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Schreinemacher, Marc H ^b   Backes, Walter H ^b,c   Slenter, Jos M ^b,c   Xanthoulea, Sofia ^b   Delvoux, Bert ^a,b   van Winden, Larissa ^b   Beets Tan, Regina G ^b   Evers, Johannes L H ^a,b   Dunselman, Gerard A J ^a,b   Romano, Andrea ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; GADOFOSVESET; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM; ORGANOMETALLIC COMPOUND;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENDOMETRIOSIS; FEMALE; HISTOPATHOLOGY; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; ANIMAL; METHODOLOGY;

MUS;

ANIMALS; CONTRAST MEDIA; ENDOMETRIOSIS; FEMALE; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MICE; ORGANOMETALLIC COMPOUNDS;

EID: 84858723399     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033241     Document Type: Article

References (36)

1. Groothuis PG, Nap AW, Winterhager E, Grummer R, (2005) Vascular development in endometriosis. Angiogenesis 8: 147-56.
2. Simoens S, Hummelshoj L, D'Hooghe T, (2007) Endometriosis: cost estimates and methodological perspective. Hum Reprod Update 13: 395-404.
3. Vigano P, Parazzini F, Somigliana E, Vercellini P, (2004) Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol 18: 177-200.
4. Simoens S, Hummelshoj L, Dunselman G, Brandes I, Dirksen C, et al. (2011) Endometriosis cost assessment (the EndoCost study): a cost-of-illness study protocol. Gynecol Obstet Invest 71: 170-6.
5. de Graaff AA, Dunselman GA, Delvoux B, van Kaam KJ, Smits LJ, et al. (2010) B lymphocyte stimulator -817C>T promoter polymorphism and the predisposition for the development of deep infiltrating endometriosis. Fertil Steril 94: 1108-10.
6. Dassen H, Punyadeera C, Schulkens I, Delvoux B, Marchetti C, et al. (2010) Olfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signalling. Am J Pathol 177: 2495-2508.
7. Delvoux B, Groothuis P, D'Hooghe T, Kyama C, Dunselman G, et al. (2009) Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism. J Clin Endocrinol Metab 94: 876-83.
8. van Kaam KJ, Romano A, Dunselman GA, Groothuis PG, (2007) Transforming growth factor beta1 gene polymorphism 509C/T in deep infiltrating endometriosis. Reprod Sci 14: 367-73.
9. van Kaam KJ, Romano A, Schouten JP, Dunselman GA, Groothuis PG, (2007) Progesterone receptor polymorphism +331G/A is associated with a decreased risk of deep infiltrating endometriosis. Hum Reprod 22: 129-35.
10. de Graaff AA, Delvoux B, Van de Vijver KK, Kyama CM, D'Hooghe TM, et al. (2012) Paired-box gene 2 is downregulated in endometriosis and correlates with low Epidermal Growth Factor Receptor expression. Hum Reprod, In press.
11. Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, et al. (2005) ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 20: 2698-704.
12. Nap AW, Groothuis PG, Demir AY, Evers JL, Dunselman GA, (2004) Pathogenesis of endometriosis. Best Pract Res Clin Obstet Gynaecol 18: 233-44.
13. Marcal L, Nothaft MA, Coelho F, Choi H, (2010) Deep pelvic endometriosis: MR imaging. Abdom Imaging 35: 708-15.
14. Brosens I, Puttemans P, Campo R, Gordts S, Kinkel K, (2004) Diagnosis of endometriosis: pelvic endoscopy and imaging techniques. Best Pract Res Clin Obstet Gynaecol 18: 285-303.
15. Stratton P, Winkel C, Premkumar A, Chow C, Wilson J, et al. (2003) Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis. Fertil Steril 79: 1078-85.
16. Rogers PA, D'Hooghe TM, Fazleabas A, Gargett CE, Giudice LC, et al. (2009) Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci 16: 335-46.
17. Nap AW, Dunselman GA, Griffioen AW, Mayo KH, Evers JL, et al. (2005) Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane. Fertil Steril 83: 793-5.
18. Nap AW, Griffioen AW, Dunselman GA, Bouma-Ter Steege JC, Thijssen VL, et al. (2004) Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 89: 1089-95.
19. Becker CM, Beaudry P, Funakoshi T, Benny O, Zaslavsky A, et al. (2011) Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis. Am J Pathol 178: 1782-91.
20. Aerts HJ, van Riel NA, Backes WH, (2008) System identification theory in pharmacokinetic modeling of dynamic contrast-enhanced MRI: influence of contrast injection. Magn Reson Med 59: 1111-9.
21. de Lussanet QG, Backes WH, Griffioen AW, Padhani AR, Baeten CI, et al. (2005) Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer. Int J Radiat Oncol Biol Phys 63: 1309-15.
22. de Lussanet QG, Langereis S, Beets-Tan RG, van Genderen MH, Griffioen AW, et al. (2005) Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice. Radiology 235: 65-72.
23. de Lussanet QG, van Golde JC, Beets-Tan RG, de Haan MW, Zaar DV, et al. (2006) Magnetic resonance angiography of collateral vessel growth in a rabbit femoral artery ligation model. NMR Biomed 19: 77-83.
24. de Lussanet QG, van Golde JC, Beets-Tan RG, Post MJ, Huijberts MS, et al. (2007) Dynamic contrast-enhanced MRI of muscle perfusion combined with MR angiography of collateral artery growth in a femoral artery ligation model. NMR Biomed 20: 717-25.
25. Somigliana E, Vercellini P, Vigano P, Benaglia L, Crosignani PG, et al. (2010) Non-invasive diagnosis of endometriosis: the goal or own goal? Hum Reprod 25: 1863-8.
26. Essig M, Nikolaou K, Meaney JF, (2007) Magnetic resonance angiography of the head and neck vessels. Eur Radiol 17 (Suppl 2): B30-7.
27. Essig M, Rohrer M, Giesel F, Tuttenberg J, Weber MA, et al. (2010) Human brain tumor imaging with a protein-binding MR contrast agent: initial experience. Eur Radiol 20: 218-26.
28. Goyen M, (2008) Gadofosveset-enhanced magnetic resonance angiography. Vasc Health Risk Manag, 2008. 4 (1): 1-9.
29. Grummer R, (2006) Animal models in endometriosis research. Hum Reprod Update 12: 641-9.
30. Bergers G, Song S, (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 7: 452-464.
31. Izquierdo E, Canete JD, Celis R, Santiago B, Usategui A, et al. (2009) Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy. PLoS One 4: e8131.
32. Coutinho A Jr, Bittencourt LK, Pires CE, Junqueira F, Lima CM, et al. (2011) MR imaging in deep pelvic endometriosis: a pictorial essay. Radiographics 31: 549-67.
33. Bazot M, Bornier C, Dubernard G, Roseau G, Cortez A, et al. (2007) Accuracy of magnetic resonance imaging and rectal endoscopic sonography for the prediction of location of deep pelvic endometriosis. Hum Reprod 22: 1457-63.
34. Bazot M, Darai E, Hourani R, Thomassin I, Cortez A, et al. (2004) Deep pelvic endometriosis: MR imaging for diagnosis and prediction of extension of disease. Radiology 232: 379-89.
35. Bazot M, Gasner A, Lafont C, Ballester M, Darai E, (2011) Deep pelvic endometriosis: Limited additional diagnostic value of postcontrast in comparison with conventional MR images. Eur J Radiol 80: e331-39.
36. Hull ML, Charnock-Jones DS, Chan CL, Bruner-Tran KL, Osteen KG, et al. (2003) Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 88: 2889-99.